keyword
https://read.qxmd.com/read/37846680/-role-of-flow-cytometry-in-the-diagnosis-of-chronic-myeloid-leukemia
#41
JOURNAL ARTICLE
Wei Huang, Rong-Rong Liu, Yuan-Yuan Wu, Si-Si Li, Yong-Min Tang
OBJECTIVE: To analyze the immunological phenotype of chronic myeloid leukemia (CML), and explore its characteristics and significance. METHODS: The immunophenotypes of 40 CML children and 40 controls were analyzed by multicolor flow cytometry. CD45/SSC, as the basic gate, was used to delineate neutrophils. Then, the distribution of cluster differentiation (CD) molecules on the surface of granulocytes was analyzed in three ranges (≥1%, ≥5%, and ≥20%), and the expression rates of CD molecules (≥1% included in the statistical analysis) and the mean fluorescence intensity (MFI) were compared between the two groups...
October 2023: Zhongguo Shi Yan Xue Ye Xue za Zhi
https://read.qxmd.com/read/37841284/unique-challenges-to-diagnosing-sweet-syndrome-following-induction-chemotherapy-for-relapsed-acute-myeloid-leukemia-aml-a-case-and-brief-review
#42
Samvel Nazaretyan, Amir Ali, George Yaghmour, Anhthy Tong, Vanessa Castillo, Sonia Rodrigues, Abdullah Ladha, Karrune Woan, Eric Tam, Samantha Y Shi, David Bateshansky, Preet M Chaudhary
BACKGROUND: Sweet Syndrome (SS) is a rare inflammatory skin condition characterized by the sudden appearance of tender, erythematous or violaceous papules, plaques, and nodules typically found on the face, neck, shoulder, upper extremities, and trunk. Often, SS is difficult to diagnose because of its various non-specific manifestations, including fever, arthralgia, myalgia and ocular involvement. In most cases described in literature, cutaneous and pulmonary symptoms of SS present in a concomitant manner...
2023: Respiratory Medicine Case Reports
https://read.qxmd.com/read/37839173/antineoplastic-effects-of-pharmacological-inhibitors-of-aurora-kinases-in-csf3r-t618i-driven-cells
#43
JOURNAL ARTICLE
Natália Sudan Parducci, Anali Del Milagro Bernabe Garnique, Keli Lima, Jorge Antonio Elias Godoy Carlos, Natasha Peixoto Fonseca, Lívia Bassani Lins de Miranda, Bruna Oliveira de Almeida, Eduardo Magalhães Rego, Fabiola Traina, João Agostinho Machado-Neto
Myeloproliferative neoplasms (MPN) are consolidated as a relevant group of diseases derived from the malfunction of the hematopoiesis process and have as a particular attribute the increased proliferation of myeloid lineage. Among these, chronic neutrophilic leukemia (CNL) is distinguished, caused by the T618I mutation of the CSF3R gene, a trait that generates ligand-independent receptor activation and downstream JAK2/STAT signaling. Previous studies reported that mutations in BCR::ABL1 and JAK2V617F increased the expression of the aurora kinase A (AURKA) and B (AURKB) in Ba/F3 cells and their pharmacological inhibition displays antineoplastic effects in human BCR::ABL1 and JAK2V617F positive cells...
October 9, 2023: Blood Cells, Molecules & Diseases
https://read.qxmd.com/read/37817276/regulatory-t-cells-contribute-to-the-immunosuppressive-phenotype-of-neutrophils-in-a-mouse-model-of-chronic-lymphocytic-leukemia
#44
JOURNAL ARTICLE
Agnieszka Goral, Marta Sledz, Aneta Manda-Handzlik, Adrianna Cieloch, Alicja Wojciechowska, Mieszko Lachota, Agnieszka Mroczek, Urszula Demkow, Radoslaw Zagozdzon, Katarzyna Matusik, Malgorzata Wachowska, Angelika Muchowicz
BACKGROUND: Impaired neutrophil activity is an important issue in chronic lymphocytic leukemia (CLL), as it contributes to a dysfunctional immune response leading to life-threatening infections in patients. Some features typical of CLL neutrophils, e.g., the B-cell-supportive secretion profile, have already been described. However, most of these studies were performed on cells isolated from peripheral blood. It is still unclear which molecular factors and cell types are involved in shaping neutrophil function and phenotype in the CLL microenvironment...
October 10, 2023: Experimental Hematology & Oncology
https://read.qxmd.com/read/37803839/-impact-of-immunosuppression-intensified-conditioning-regimen-for-patients-with-strong-positive-pre-transplantation-donor-specific-anti-hla-antibodies-dsas-undergoing-haploidentical-hematopoietic-stem-cell-transplantation
#45
JOURNAL ARTICLE
H X Liu, D L Wei, S Shao, Y Jiang, S Li, J Zhu, C Wang, C X Zhao
Objective: To explore the efficacy of immunosuppression intensified conditioning regimen in patients who have strongly positive donor-specific Anti-HLA antibodies (DSAs) and received a haploidentical hematopoietic stem cell transplantation (haplo-HSCT) . Methods: Clinical data of 10 patients with strongly positive pretransplant DSAs (defined as MFI ≥10000) were retrospectively analyzed in this study. All of them received a haplo-HSCT in the Hematology Department of Shanghai Zhaxin Traditional Chinese & Western Medicine Hospital...
August 14, 2023: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/37790742/young-woman-with-unexplained-neutropenia-and-neutrophils-with-bilobed-nuclei-marrow-findings
#46
Martin Barnes, Victoria Shklar, Dipen Patel, Harry Staszewski
A 27-year-old female with a history of chronic sinusitis was referred for the evaluation of asymptomatic neutropenia. The differential demonstrated a mild neutropenia, which eventually resolved on subsequent evaluation. The liver and the spleen were not palpable. Peripheral flow cytometry was normal. Peripheral blood smear (PBS) demonstrated numerous Pelger-Huet anomalous neutrophils with characteristic "pince-nez" nuclei, without significant abnormalities in the other cell lines. Due to the benign clinical nature of hereditary PHA, a bone marrow biopsy is almost never required...
2023: Case Reports in Hematology
https://read.qxmd.com/read/37775358/the-effect-of-cryopreservation-on-engraftment-kinetics-in-fully-matched-allogeneic-stem-cell-transplantation-real-life-data-and-literature-review
#47
JOURNAL ARTICLE
Tuba Ersal, Vildan Özkocaman, Cumali Yalçın, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, İbrahim Ethem Pınar, Fazıl Çağrı Hunutlu, Fahir Özkalemkaş
INTRODUCTION: The standard approach for allogeneic stem cell transplantation (allo-SCT) is to administer donor cells on the same day as a fresh product to a patient who has been given a preparative regimen. The difficulty in collecting and transporting donor cells, especially during the COVID-19 pandemic, has made it essential to collect and cryopreserve the grafts before the recipient begins the transplant preparation regimen. However, the short- and long-term impacts of cryopreservation on transplant outcomes remain controversial...
September 18, 2023: Transfusion and Apheresis Science
https://read.qxmd.com/read/37760777/the-value-of-neutrophil-gelatinase-associated-lipocalin-receptor-as-a-novel-partner-of-cd38-in-chronic-lymphocytic-leukemia-from-an-adverse-prognostic-factor-to-a-potential-pharmacological-target
#48
JOURNAL ARTICLE
Brigitte Bauvois, Elise Chapiro, Claire Quiney, Karim Maloum, Santos A Susin, Florence Nguyen-Khac
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of neoplastic B lymphocytes that escape death, and correlates with the expression of negative prognostic markers such as the CD38 antigen. Although certain new drugs approved by the US Food and Drug Administration improve the clinical outcome of CLL patients, drug resistance and disease relapse still occur. Like CD38, neutrophil gelatinase-associated lipocalin receptor (NGAL-R) is frequently overexpressed in CLL cells. Here, we evaluated the concomitant surface expression of NGAL-R and CD38 in leukemic blood cells from 52 CLL patients (37 untreated, 8 in clinical remission, and 7 relapsed)...
August 22, 2023: Biomedicines
https://read.qxmd.com/read/37749039/-efficacy-and-safety-of-tbi-ratg-based-conditioning-regimen-for-haploidentical-allogeneic-hematopoietic-stem-cell-transplantation-in-11-cases-of-chemotherapy-resistant-advanced-peripheral-t-cell-lymphoma
#49
JOURNAL ARTICLE
R Xu, S Li, H X Liu, D L Wei, Y Jiang, J J Wang, S S Liu, C Wang, J Zhu
Objective: To evaluate the clinical outcomes and safety of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) using a conditioning regimen based on total body irradiation (TBI) and rabbit anti-human thymocyte globulin (rATG) in the management of chemotherapy-resistant advanced peripheral T-cell lymphoma (PTCL) . Methods: Clinical data of 11 patients with chemotherapy-resistant advanced PTCL who underwent haplo-HSCT with a TBI+rATG-based conditioning regimen at the Department of Hematology, Shanghai Liquan Hospital and Shanghai Zhaxin Integrated Traditional Chinese and Western Medicine Hospital, from September 2019 to December 2022 were retrospectively analyzed...
July 14, 2023: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/37748539/haplo-cord-transplantation-with-8mg-kg-anti-thymocyte-globulin-as-graft-versus-host-disease-prophylaxis-compared-to-haploidentical-transplantation-with-10mg-kg-anti-thymocyte-globulin-in-the-treatment-of-acute-leukemia
#50
JOURNAL ARTICLE
Fangfang Yuan, Gangping Li, Minghui Li, Xudong Wei, Yuewen Fu
BACKGROUND: Clinical outcomes of the transplantation strategy combined with a haploidentical stem cell graft and an unrelated umbilical cord blood unit (haplo-cord HSCT) with low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for the treatment of acute leukemia (AL) remains unclear. OBJECTIVE: This study aimed to explore the clinical outcomes of haplo-cord HSCT in acute leukemia patients with the GVHD prevention strategy of 8 mg/kg ATG compared with haplo- transplantation with 10 mg/kg ATG...
September 23, 2023: Transplantation and cellular therapy
https://read.qxmd.com/read/37736096/case-report-unedited-allogeneic-chimeric-antigen-receptor-t-cell-bridging-to-conditioning-free-hematopoietic-stem-cell-transplantation-for-a-child-with-refractory-burkitt-lymphoma
#51
Xiaomin Yang, Chengjuan Luo, Juan Qian, Xiaohang Huang, Jian Zhang, Jianmin Wang, Changying Luo, Xia Qin, Benshang Li, Jing Chen
PURPOSE: Burkitt lymphoma (BL) is the most common tumor of non-Hodgkin's lymphoma (NHL) in children, accounting for about 40% of cases. Although different combined short-course chemotherapies have achieved a good effect, refractory/relapsed BL has a poor prognosis with cure rates less than 30%. Chimeric antigen receptor T cell (CAR-T) therapy has developed rapidly in recent years and achieved excellent results in acute lymphoblastic leukemia (ALL). However, in some cases, there is a failure to produce autologous CAR-T cells because of T-cell dysfunction...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37705244/myelodysplasia-after-clonal-hematopoiesis-with-apobec3-mediated-cybb-inactivation-in-retroviral-gene-therapy-for-x-cgd
#52
JOURNAL ARTICLE
Toru Uchiyama, Toshinao Kawai, Kazuhiko Nakabayashi, Yumiko Nakazawa, Fumihiro Goto, Kohji Okamura, Toyoki Nishimura, Koji Kato, Nobuyuki Watanabe, Akane Miura, Toru Yasuda, Yukiko Ando, Tomoko Minegishi, Kaori Edasawa, Marika Shimura, Yumi Akiba, Aiko Sato-Otsubo, Tomoyuki Mizukami, Motohiro Kato, Koichi Akashi, Hiroyuki Nunoi, Masafumi Onodera
Stem cell gene therapy using the MFGS-gp91phox retroviral vector was performed on a 27-year-old patient with X-linked chronic granulomatous disease (X-CGD) in 2014. The patient's refractory infections were resolved, whereas the oxidase-positive neutrophils disappeared within 6 months. Thirty-two months after gene therapy, the patient developed a myelodysplastic syndrome (MDS), and vector integration into the MECOM locus was identified in blast cells. The vector integration into MECOM was detectable in most myeloid cells at 12 months after gene therapy...
September 12, 2023: Molecular Therapy
https://read.qxmd.com/read/37673624/-granulocyte-colony-stimulating-factor-producing-multiple-myeloma-presenting-with-neutrophilia
#53
JOURNAL ARTICLE
Momoko Yokoi, Toshinori Kondo, Risa Shimizu, Keiichi Uchida, Shigeki Hayashi, Hirotake Nishimura, Eisei Kondo, Hideho Wada
A 71-year-old woman complained of nausea and anorexia. Laboratory tests revealed significant neutrophilia and immunoglobulin A-kappa type M proteinemia, as well as increased plasma cells on bone marrow examination. Furthermore, the serum granulocyte-colony stimulating factor (G-CSF) concentration was high at 160 pg/ml, and the colony stimulating factor 3 receptor (CSF3R)-T618I mutation was negative. Immunohistochemical (IHC) analysis of bone marrow specimens using the anti-G-CSF antibody revealed immunopositivity of some myeloma cells...
2023: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/37648032/relevance-of-vitamin-d-in-patients-undergoing-hla-matched-allogeneic-stem-cell-transplant-for-acute-leukemia
#54
JOURNAL ARTICLE
Nishant Jindal, Megha Saroha, Sumeet Mirgh, Akanksha Chichra, Lingaraj Nayak, Avinash Bonda, Anant Gokarn, Sachin Punatar, Bhausaheb Bagal, Preeti Chavan, Libin Jacob Mathew, Sadhana Kanan, Navin Khattry
BACKGROUND: In hematopoietic stem cell transplant (HSCT), vitamin D deficiency has been variably associated with increased complications, primarily graft versus host disease (GvHD), with a potential impact on survival. Results from various studies however, have not been consistent. This analysis was conducted to study the impact of peri-transplant vitamin D levels on transplant outcomes in patients with acute leukemia (AL) who underwent HLA matched (related/unrelated) HSCT. METHODS: This was a single center retrospective study...
August 28, 2023: Transplant Immunology
https://read.qxmd.com/read/37601857/when-monoclonal-gammopathy-associated-chronic-neutrophilic-leukemia-is-a-reactive-process-distinct-from-a-clonal-myeloproliferative-neoplasm-lessons-from-mistakes
#55
Christophe Willekens, Claude Chahine, Matteo Dragani, Sabine Khalife-Hachem, Camille Bigenwald, Julien Rossignol, Cristina Castilla-Llorente, Alina Danu, Jean-Marie Michot, Veronique Saada, Sophie Cotteret, Christophe Marzac, Aline Renneville, Isabelle Plo, Sophie Broutin, Nelly Bosselut, Bruno Cassinat, Julien Lazarovici, Nathalie Droin, Stephane De Botton
No abstract text is available yet for this article.
August 2023: EJHaem
https://read.qxmd.com/read/37550202/-effect-and-safety-of-10-day-decitabine-containing-conditioning-regimen-for-allogeneic-hematopoietic-stem-cell-transplantation-in-31-patients-with-acute-myeloid-leukemia-myelodysplastic-syndrome
#56
JOURNAL ARTICLE
J Liu, Y G Cao, R L Zhang, W H Zhai, X Chen, Q L Ma, A M Pang, D L Yang, J L Wei, Y He, S Z Feng, M Z Han, E L Jiang
Objective: To investigate the early effect and safety of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with a 10-day decitabine-containing conditioning regimen in the treatment of acute myeloid leukemia (AML) /myelodysplastic syndrome (MDS) . Methods: From April 2021 to May 2022, 31 AML/MDS patients who received allo-HSCT with a 10-day decitabine-containing conditioning regimen were analyzed. Results: AML ( n =10), MDS-AML ( n =6), CMML-AML ( n =1), and MDS ( n =14) were identified in 31 patients, 16 males, and 15 females, with a median age of 41 (20-55) yr...
June 14, 2023: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/37550200/-efficacy-and-safety-of-secondary-allogeneic-hematopoietic-stem-cell-transplantation-in-70-patients-with-recurrent-hematologic-malignancies-after-transplantation
#57
JOURNAL ARTICLE
T T Han, Y Liu, Y Chen, Y Y Zhang, H X Fu, C H Yan, X D Mo, F R Wang, J Z Wang, W Han, Y Y Chen, H Chen, Y Q Sun, Y F Cheng, Y Wang, X H Zhang, X J Huang, L P Xu
Objectives: To investigate the role of donor change in the second hematopoietic stem cell transplantation (HSCT2) for hematological relapse of malignant hematology after the first transplantation (HSCT1) . Methods: We retrospectively analyzed patients with relapsed hematological malignancies who received HSCT2 at our single center between Mar 1998 and Dec 2020. A total of 70 patients were enrolled[49 males and 21 females; median age, 31.5 (3-61) yr]. Results: Forty-nine male and 21 female patients were enrolled in the trial...
June 14, 2023: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/37536453/selection-of-cord-blood-unit-by-cd34-cell-number-cfu-gm-number-and-allele-level-hla-matching-in-single-cord-blood-transplantation
#58
JOURNAL ARTICLE
Yasuo Morishima, Naoko Watanabe-Okochi, Syunro Kai, Fumihiro Azuma, Takafumi Kimura, Kayoko Matsumoto, Shizuyo Hatasa, Nobuo Araki, Akira Miyamoto, Tatsuya Sekimoto, Mutsuko Minemoto, Hiroyuki Ishii, Naoyuki Uchida, Satoshi Takahashi, Masatsugu Tanaka, Naoki Shingai, Shigesaburo Miyakoshi, Yasuji Kozai, Makoto Onizuka, Tetsuya Eto, Fumihiko Ishimaru, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Minoko Takanashi, Koji Kato
BACKGROUND: In Japan only single cord blood transplantations (CBTs) are typically performed and their number has increased over 23 years, with ongoing improvement in the results. CBTs with multiple HLA mismatches are usually employed due to a low HLA barrier, and lower engraftment rate is one of problems to overcome. OBJECTIVE: Here, as part of efforts to improve guidelines for the selection and processing of cord blood units for transplantation, we sought to assess the present status of CBTs in Japan, and to elucidate factors contributing to the favorable outcomes, especially focusing on the selection by cell components of cord blood (CB) unit and HLA allele matching...
August 1, 2023: Transplantation and cellular therapy
https://read.qxmd.com/read/37470656/tyrosine-kinase-inhibitor-therapies-in-chronic-myeloid-leukemia-effects-on-clinical-characteristics-and-triglyceride-to-high-density-lipoprotein-cholesterol-ratio
#59
JOURNAL ARTICLE
E T Erkek, A C Isik, Y Ipek, A N Kul
BACKGROUND AND AIM: Tyrosine kinase inhibitors (TKIs) have dramatically improved chronic myeloid leukemia (CML) prognosis. However, TKIs are associated with dyslipidemia and impaired glucosehomeostasis. Triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) is proposed to be an indicator of insulin resistance and atherogenic index, but there is no research on TG/HDL-C alterations in patients receiving TKIs for CML. We aimed to evaluate relationships between TKI type/count, clinical characteristics, and laboratory results (particularly TG/HDL-C) in CML patients...
June 2023: Nigerian Journal of Clinical Practice
https://read.qxmd.com/read/37456801/differential-diagnoses-and-the-mutational-landscape-of-myelodysplastic-myeloproliferative-neoplasm-with-neutrophilia-a-case-report
#60
Bernhard Strasser, Monika Grünberger, Rita Steindl, Sonja Heibl, Josef Thaler, Alexander Haushofer
Myelodysplastic/myeloproliferative neoplasm with neutrophilia (MDS/MPN-N; previously referred to as atypical chronic myeloid leukemia) is a type of myelodysplastic syndrome/myeloproliferative neoplasm. A molecular genetic precondition for diagnosis is BCR::ABL negativity; further diagnostic criteria include clinicopathological assessments, such as peripheral blood leukocyte counts, the number of neutrophils and their precursors, and the presence of dysgranulopoiesis. The present case report highlights the importance of differential diagnoses with a stringent diagnostic workup according to the 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors...
August 2023: Molecular and Clinical Oncology
keyword
keyword
38998
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.